Stockscreener 앱 받기
17.94
1.24%
-0.27
시간 외 거래:
17.94
전일 마감가:
$18.21
열려 있는:
$18.18
하루 거래량:
9.93M
Relative Volume:
1.42
시가총액:
$9.22B
수익:
$10.89B
순이익/손실:
$-241.00M
주가수익비율:
-67.55
EPS:
-0.2656
순현금흐름:
$340.00M
1주 성능:
-21.33%
1개월 성능:
-24.62%
6개월 성능:
-41.44%
1년 성능:
-49.76%
1일 변동 폭
$17.74
$18.32
1주일 범위
$17.74
$22.92
52주 변동 폭
$17.74
$37.74
박스터 인터내셔널 Stock (BAX) Company Profile
명칭
Baxter International Inc
전화
(224) 948-2000
주소
ONE BAXTER PARKWAY, DEERFIELD, IL
BAX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
17.95 | 9.35B | 10.89B | -241.00M | 340.00M | -0.2656 |
|
ISRG
Intuitive Surgical Inc
|
538.82 | 192.92B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
179.04 | 50.82B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
ALC
Alcon Inc
|
74.18 | 36.53B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
RMD
Resmed Inc
|
246.39 | 36.34B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
WST
West Pharmaceutical Services Inc
|
287.25 | 20.13B | 2.96B | 487.70M | 344.00M | 6.6758 |
박스터 인터내셔널 Stock (BAX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-31 | 다운그레이드 | Argus | Buy → Hold |
| 2025-08-04 | 다운그레이드 | Stifel | Buy → Hold |
| 2025-08-01 | 다운그레이드 | Goldman | Buy → Neutral |
| 2025-02-26 | 재개 | Goldman | Buy |
| 2025-02-24 | 업그레이드 | Argus | Hold → Buy |
| 2025-02-20 | 재개 | Barclays | Overweight |
| 2024-07-15 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2024-05-30 | 개시 | Goldman | Neutral |
| 2024-05-10 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2023-05-30 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-03-29 | 개시 | UBS | Neutral |
| 2023-01-06 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-05 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-01-03 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-12-19 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-12-15 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2022-12-12 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-06-24 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | 다운그레이드 | Goldman | Neutral → Sell |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-02-18 | 재확인 | KeyBanc Capital Markets | Overweight |
| 2022-02-18 | 재확인 | Morgan Stanley | Overweight |
| 2022-02-18 | 재확인 | Raymond James | Outperform |
| 2022-02-18 | 재확인 | Stifel | Buy |
| 2022-02-18 | 재확인 | UBS | Neutral |
| 2022-02-18 | 재확인 | Wells Fargo | Overweight |
| 2022-02-11 | 개시 | Goldman | Neutral |
| 2022-01-07 | 재개 | Citigroup | Buy |
| 2022-01-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2021-09-13 | 업그레이드 | Cowen | Market Perform → Outperform |
| 2021-09-03 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2021-05-25 | 개시 | Barclays | Equal Weight |
| 2021-01-29 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-01-06 | 다운그레이드 | UBS | Buy → Neutral |
| 2020-12-15 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-10-01 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-09-04 | 다운그레이드 | Argus | Buy → Hold |
| 2020-06-24 | 개시 | Oppenheimer | Outperform |
| 2020-03-19 | 업그레이드 | Stifel | Hold → Buy |
| 2020-03-18 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-05 | 개시 | Citigroup | Neutral |
| 2020-02-13 | 개시 | Goldman | Buy |
| 2020-01-02 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2019-12-17 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-26 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2019-04-08 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-01-02 | 업그레이드 | Citigroup | Neutral → Buy |
| 2019-01-02 | 업그레이드 | Morgan Stanley | Underweight → Overweight |
| 2018-11-02 | 업그레이드 | Argus | Hold → Buy |
| 2018-10-16 | 개시 | Barclays | Underweight |
| 2018-05-17 | 재개 | Piper Jaffray | Overweight |
| 2018-02-06 | 재확인 | Citigroup | Neutral |
| 2018-01-03 | 개시 | Evercore ISI | Outperform |
| 2018-01-03 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
모두보기
박스터 인터내셔널 주식(BAX)의 최신 뉴스
December 15, 2025 Deadline: Join Class Action Lawsuit Against Baxter International, Inc. (BAX)Contact Levi & Korsinsky - The Globe and Mail
BAX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International - GlobeNewswire
BAX Investors Have Opportunity to Lead Baxter International Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
Don't Write Off Baxter Just Yet (NYSE:BAX) - Seeking Alpha
Day 5 of Loss Streak for Baxter International Stock with -21% Return (vs. -36% YTD) [11/3/2025] - Trefis
Non-PVC IV Bags Market Poised for Rapid Explosive Growth| Baxter - openPR.com
How Attractive Is Baxter After a 21% Weekly Drop and Strategic Divestitures in 2025? - simplywall.st
Class Action Filed Against Baxter International, Inc. (BAX) - GlobeNewswire
Deadline Alert: Baxter International, Inc. (BAX) - GlobeNewswire
Deadline Alert: Baxter International, Inc. (BAX) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - GlobeNewswire Inc.
Lowey Dannenberg Notifies Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $250,000 in Losses to Contact the Firm - GlobeNewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International - Morningstar
Baxter International, Inc. Securities Fraud Class Action Lawsuit - GuruFocus
Baxter International, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before December 15, 2025 to Discuss Your RightsBAX - Morningstar
United States Vitiligo Forecast Report 2025: A $320+ Million Market by 2033 Featuring Incyte, BMS, Clinuvel Pharmaceuticals, Astellas Pharma, Baxter, Pfizer, Dr. Reddy's LaboratoriesResearchAndMarkets.com - FinancialContent
Investor Alert: Deadline Approaching to Join Baxter International, Inc. (BAX) Class ActionContact Levi & Korsinsky - The Globe and Mail
What Developments Are Shaping the Narrative for Baxter International’s Future? - Yahoo! Finance Australia
Baxter International (BAX) Stock Plunges on Q3 2025 Revenue Miss and Guidance CutNews and Statistics - IndexBox
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Baxter International Inc. with Losses of $100,000 to Contact the Firm - Lelezard
2025-11-03 | December 15, 2025 Deadline Approaching: Join Class Action Against Baxter International, Inc. (BAX)Contact Levi & Korsinsky | NYSE:BAX | Press Release - Stockhouse
Is Wall Street Bullish or Bearish on Baxter International Stock? - Barchart.com
BAXTER INTERNATIONAL INC. (NYSE: BAX) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Baxter ... - Bluefield Daily Telegraph
BAXTER INTERNATIONAL INC. (NYSE: BAX) SHAREHOLDER ALERT - GlobeNewswire
How Baxter International Inc. stock performs during market turbulenceWeekly Trend Report & AI Driven Stock Price Forecasts - newser.com
Why Baxter International Inc. stock is a must watch ticker2025 Performance Recap & Advanced Technical Analysis Signals - newser.com
Key facts: Baxter International halts Novum LVP shipments; class action filed - TradingView
Research Alert: CFRA Keeps Sell Rating On Shares Of Baxter International Inc. - 富途牛牛
Baxter International (NYSE:BAX) Price Target Cut to $19.00 by Analysts at JPMorgan Chase & Co. - MarketBeat
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Baxter International Inc. Investors to Secure ... - Bluefield Daily Telegraph
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Baxter International Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International - Newsfile
Cooke & Bieler LP Increases Holdings in Baxter International Inc. $BAX - MarketBeat
The Goldman Sachs Group Lowers Baxter International (NYSE:BAX) Price Target to $22.00 - Defense World
Baxter International (NYSE:BAX) Stock Rating Lowered by Argus - Defense World
Baxter International Stock Hits Day Low of $18.44 Amid Price Pressure - Markets Mojo
UBS Group Issues Pessimistic Forecast for Baxter International (NYSE:BAX) Stock Price - Defense World
2025-11-01 | December 15, 2025 Deadline Approaching: Join Class Action Against Baxter International, Inc. (BAX)Contact Levi & Korsinsky | NYSE:BAX | Press Release - Stockhouse
Baxter International Inc. stock trend outlook and recovery path2025 Valuation Update & Daily Chart Pattern Signals - newser.com
Baxter International Inc. (NYSE:BAX) Q3 2025 Earnings Call Transcript - Insider Monkey
Jefferies Financial Group Has Lowered Expectations for Baxter International (NYSE:BAX) Stock Price - MarketBeat
Evercore ISI Issues Pessimistic Forecast for Baxter International (NYSE:BAX) Stock Price - MarketBeat
Baxter International (NYSE:BAX) Rating Lowered to "Hold" at Argus - MarketBeat
Forecasting Baxter International Inc. price range with options dataJuly 2025 Market Mood & Weekly Setup with High ROI Potential - newser.com
Is Baxter International Inc. stock a good choice for value investorsJuly 2025 Outlook & Consistent Profit Alerts - newser.com
Baxter Q3 2025 sales increase 5% to USD 2.84B - Medical Buyer
Baxter International (NYSE:BAX) Announces Quarterly Earnings Results - MarketBeat
Baxter International’s Earnings Call: Growth Amid Challenges - TipRanks
Citigroup Lowers Price Target for Baxter Intl (BAX) to $21 | BAX Stock News - GuruFocus
Why Baxter (BAX) Shares Are Sliding Today - TradingView
Baxter International (BAX): Losses Worsen as Investors Weigh Turnaround Hopes Against Ongoing Financial Risks - Sahm
Class Action Filed Against Baxter International, Inc. (BAX) Seeking Recovery for Investors – ... - Bluefield Daily Telegraph
박스터 인터내셔널 (BAX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.16%
0.98%
자본화:
|
볼륨(24시간):